Company information for MabGenesis Inc. has been published. The company is listed on the TSE under ticker 653A, was established in 2019, operates in the pharmaceuticals and biotechnology industry, and has a reported market capitalization of approximately ¥6.685 billion.
Company information for MabGenesis Inc. has been published, showing ticker 653A and a listing on the TSE (Tokyo Stock Exchange).
The company is said to have been established in 2019 and is classified in the pharmaceuticals industry and the pharmaceuticals and biotechnology sector.
Its market capitalization is stated as JP¥6.685b, listed among the key points of its company information.